Genetics may improve predictive ability of Framingham risk function for coronary heart disease

Carlos Iribarren, MD, MPH, PhD and Senior Research Scientist at Kaiser Permanente of North California discusses improving the clinical utility of the Framingham Risk function for incident coronary heart disease by the addition of weighted multi-marker genetic risk scores in more than 40,000 individuals at the American College of Cardiology 65th Annual Scientific Session & Expo (ACC.16).

MDLinx Conference Coverage - American College of Cardiology 65th Annual Scientific Session & Expo (ACC.16): http://www.mdlinx.com/cardiology/conf...

MDLinx: http://www.mdlinx.com/
Smartest Doc & Board Exam Prep: http://www.thesmartestdoc.com/
M3 USA: http://usa.m3.com/

Follow MDLinx:
Facebook -   / mdlinx  
Twitter -   / mdlinx  
Google+ - https://plus.google.com/+Mdlinx/